Pluri 2025 Q3 Earnings Revenue Surges as Net Loss Widens

Pluri (PLUR) reported its fiscal 2025 Q3 earnings on May 13th, 2025. The total revenue of Pluri increased by 501.4% to $427,000 in 2025 Q3, up from $71,000 in 2024 Q3. Pluri narrowed losses to $0.94 per share in 2025 Q3 from a loss of $1.01 per share in 2024 Q3 (6.9% improvement). However, the company's net loss widened to $-6.33 million in 2025 Q3, representing a 17.5% increase from the $-5.39 million loss recorded in 2024 Q3. Investors should consider the mixed financial results and ongoing challenges highlighted by the company's sustained losses for nine years over corresponding fiscal quarters.

Revenue

The total revenue of Pluri increased by 501.4% to $427,000 in 2025 Q3, up from $71,000 in 2024 Q3.

Earnings/Net Income

Pluri narrowed losses to $0.94 per share in 2025 Q3 from a loss of $1.01 per share in 2024 Q3 (6.9% improvement). Meanwhile, the company's net loss widened to $-6.33 million in 2025 Q3, representing a 17.5% increase from the $-5.39 million loss recorded in 2024 Q3. The EPS improvement shows progress despite the widening net loss.

Price Action

The stock price of Pluri has climbed 3.08% during the latest trading day, has jumped 11.00% during the most recent full trading week, and has surged 43.05% month-to-date.

Post-Earnings Price Action Review

The strategy of purchasing Pluri shares after a revenue increase on the earnings report release date and holding them for 30 days has yielded moderate returns over the past five years, albeit with some volatility. From May 2020 to May 2025, this approach achieved a compound annual growth rate (CAGR) of approximately 10%, premised on the idea that the 30-day holding period would capture some post-earnings momentum. While this strategy demonstrated potential for gains, particularly in years marked by significant post-earnings momentum, it also exposed investors to volatility, notably in months following earnings releases. For instance, a substantial pullback occurred after the initial rally in May 2020. Investors should also weigh tax implications, as short-term capital gains may be taxed at a higher rate than long-term gains. In conclusion, while the strategy showed promise, investors must consider the volatility and risks, particularly concerning tax impacts and market fluctuations.

CEO Commentary

Pluri's CEO emphasized the company's strategic moves towards enhancing its market position and revenue generation, highlighting a revenue of $427,000 for Q3 2025. The CEO acknowledged challenges but expressed confidence in overcoming them through innovative product development and strategic acquisitions, such as the recent investment in Kokomodo Ltd., which integrates cultivated cacao into Pluri's offerings. The leadership remains optimistic about future growth, focusing on expanding their cell-based solutions across various sectors, thereby driving sustainable business performance.

Guidance

Pluri anticipates continued revenue growth, projecting an EPS of -$0.94 for the upcoming quarter. The company is committed to increasing its market share through strategic investments and collaborations, aiming to enhance operational efficiencies and product offerings. The leadership expects to leverage recent partnerships to bolster revenue streams and improve overall financial health in the coming periods.

Additional News

Pluri Inc. has recently completed the strategic acquisition of a 71% equity stake in Kokomodo Ltd., a cultivated cacao AgFoodTech company, for $4.5 million in Pluri common shares. This acquisition strengthens Pluri's push into sustainable food technologies by combining its mass-scale cell production expertise with Kokomodo's climate-resilient cacao cultivation via cellular agriculture. Kokomodo will continue operating independently as a Pluri subsidiary, maintaining its mission, team, and brand identity. The collaboration is expected to accelerate production scale-up, global market entry, and product innovation in sustainable cacao ingredients. Additionally, Pluri has secured an additional $3.5 million investment from Merchant Adventure Fund, L.P., a major existing shareholder, bringing total recent financings to $10 million. This investment supports Pluri's growth strategy as a global leader in cell-based technology, enabling expansion across pharma, foodtech, and agtech industries.